The upregulation of endogenous PBK/TOPK augmented resistance of human HeLa cervical cancer cells to TRAIL-induced apoptosis, while PBK/TOPK knockdown noticeably increased doxorubicin-mediated apoptosis [55]. The gene discussed is PBK; the disease is cervical carcinoma.